Tazarotene cream (0.1%) in combination with betamethasone valerate foam (0.12%) for plaque-type psoriasis.

Journal of drugs in dermatology : JDD

Volumn 4, Issue 2, 2005, Pages 228-230

  Dhawan, Sunil S ^a   Blyumin, Marianna L ^a   Pearce, Daniel J ^a   Feldman, Steven R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE VALERATE; NICOTINIC ACID DERIVATIVE; TAZAROTENE;

ARTICLE; DRUG COMBINATION; HUMAN; OINTMENT; PSORIASIS;

BETAMETHASONE 17-VALERATE; DRUG THERAPY, COMBINATION; HUMANS; NICOTINIC ACIDS; OINTMENTS; PSORIASIS;

EID: 19444384890     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)